FDA Adverse Event Malfunction Summary report: N

ADULT NASAL CANNULA

MDR report key: 3345578 · Received August 22, 2013

Report

Report Number
9680866-2013-00003
Event Type
Malfunction
Date Received
August 22, 2013
Date of Event
July 24, 2013
Report Date
July 25, 2013
Manufacturer
UNOMEDICAL S.A. DE C.V.
Product Code
CAT
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

PRODUCT WAS NOT IN USE. BASED ON AVAILABLE INFORMATION, THE RECURRENCE OF THIS MALFUNCTION MAY POSSIBLY LEAD TO A SERIOUS INJURY BECAUSE A DEFORMED/BROKEN/OR EMBEDDED OXYGEN TUBING THAT DOES NOT DELIVER THE OXYGEN A PATIENT REQUIRES CAN JEOPARDIZE STABILITY AND PLACE THE PATIENT INTO A HEMODYNAMICALLY UNSTABLE CONDITION. IT IS EXPECTED THAT THE PRODUCT WITH THE FOREIGN MATTER OR DEFORMITY ON/IN ITS PACKAGING WOULD NOT LIKELY BE USED AS THIS PROBLEM WOULD BE DISCOVERED ON RECEIPT OF THE PRODUCT. THE AFFECTED PRODUCTS WOULD BE EXPECTED TO BE REPLACED. A PRELIMINARY INVESTIGATION, BASED ON THE EXAMINATION OF A PICTURE PROVIDED BY THE CUSTOMER, INDICATED THAT IT IS DIFFICULT TO DETERMINE IF THE PRODUCT MEETS SPECIFICATION. THE ACCEPTANCE CRITERIA FOR CRACKS IN THE INSPECTION (PROCEDURE F802058) STATES THERE IS NO AFFECT ON THE DEVICE FUNCTION; HOWEVER, WITHOUT A COMPLAINT SAMPLE, WE ARE UNABLE TO VERIFY IF THE REPORTED BROKEN COMPONENT AFFECTED THE DEVICE FUNCTION.

Description of Event or Problem · 1

CUSTOMER REPORTED TO THE DISTRIBUTOR THAT THEY FOUND SOME COSMETIC ISSUES DURING AN 100% INCOMING INSPECTION. THERE WERE MARKS ON THE CANNULA AS BROKEN, DEFORMATIONS AND EMBEDDED PARTICLES. MORE INFORMATION WAS REQUESTED FROM THE CUSTOMER DUE TO THE UNSPECIFIED SIZE OF THE EMBEDDED PARTICLES AND TO DETERMINE IF THE DEFORMATION AND MARKS HAD AN EFFECT ON THE PRODUCT PERFORMANCE. THE PRODUCT WAS NOT USED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
408302 ADULT NASAL CANNULA NASAL OXYGEN CANNULA CAT UNOMEDICAL S.A. DE C.V. H1820 12-34

Patients

Seq Age Sex Outcome Treatment
1